Odyssey Therapeutics, Inc. <ODTX.O>: H.C. Wainwright initiates coverage with buy rating and target price $44
ODTX•Related News
Meta's social media settlement leaves its money machine unscathed
META•
Healthy Choice Wellness sets up at-the-market share sale program for up to $2.63 million
HCWC•
Everpure Inc <P.N>: Citigroup raises target price to $130 from $118
P•
Zhihu files HKEX next-day return disclosing share repurchase for cancellation
ZH•
Ducommun CEO Oswald to join B. Riley Consumer & TMT Conference investor meetings
DCO•